BRISDELLE (Sebela Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the BRISDELLE drug offered from Sebela Pharmaceuticals Inc.. This Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sebela Pharmaceuticals Inc.
NON-PROPRIETARY NAME: paroxetine
SUBSTANCE NAME: PAROXETINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-05-23
END MARKETING DATE: 0000-00-00


BRISDELLE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBRISDELLE from Sebela Pharmaceuticals Inc.
LABELER NAME: Sebela Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/1)
START MARKETING DATE: 2017-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54766-907_50361fc8-8fbb-1c45-e054-00144ff88e88
PRODUCT NDC: 54766-907
APPLICATION NUMBER: NDA204516

Other PAROXETINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
NOVEN THERAPEUTICS, LLCPEXEVA
Noven Therapeutics, LLCBRISDELLE
Paddock Laboratories, LLCParoxetine
REMEDYREPACK INC.PEXEVA
Sebela Pharmaceuticals Inc.PEXEVA
Solco Healthcare LLCPAROXETINE